Serveur d'exploration Covid (26 mars) - Exploration (Accueil)

Index « Mesh.i » - entrée « Viral Vaccines »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Viral Tropism < Viral Vaccines < Virion  Facettes :

List of bibliographic references indexed by Viral Vaccines

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000210 (2020) Shan Lu [États-Unis]Timely development of vaccines against SARS-CoV-2.
000467 (2020) Syed Faraz Ahmed [République populaire de Chine] ; Ahmed A. Quadeer [République populaire de Chine] ; Matthew R. Mckay [République populaire de Chine]Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
000480 (2020) Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine]Potential interventions for novel coronavirus in China: A systematic review.
000486 (2020) David A. Schwartz [États-Unis] ; Ashley L. GrahamPotential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
000581 (2020) Fei Yu [République populaire de Chine] ; Lanying Du [États-Unis] ; David M. Ojcius [États-Unis] ; Chungen Pan [République populaire de Chine] ; Shibo Jiang [République populaire de Chine]Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.
000670 (2020) Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande]Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
000828 (2020) Shibo JiangDon't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.
000A37 (2020) Ewen Callaway ; David CyranoskiChina coronavirus: Six questions scientists are asking.
001528 (2009) Jin Young Chung [Corée du Sud] ; Eui Jae Sung ; Chun Gyu Cho ; Kyoung Won Seo ; Jong-Soo Lee ; Dong Ha Bhang ; Hee Woo Lee ; Cheol Yong Hwang ; Wan Kyu Lee ; Hwa Young Youn ; Chul Joong KimEffect of recombinant lactobacillus expressing canine GM-CSF on immune function in dogs.
001687 (2007) Masaji Okada [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Yoko Kita [Japon] ; Noriko Kanamaru [Japon] ; Yasuko Nishida [Japon] ; Yoshie Tsunai [Japon] ; Ruriko Inoue [Japon] ; Hitoshi Nakatani [Japon] ; Reiko Fukamizu [Japon] ; Yumi Namie [Japon] ; Junko Yamada [Japon] ; Kyoko Takao [Japon] ; Ritsuko Asai [Japon] ; Ryoko Asaki [Japon] ; Tetsuo Kase [Japon] ; Yuji Takemoto [Japon] ; Shigeto Yoshida [Japon] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
001786 (2005) Masaji Okada [Japon] ; Yuji Takemoto [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Shigeto Yoshida [Japon] ; Yukari Fukunaga [Japon] ; Takao Tanaka [Japon] ; Yoko Kita [Japon] ; Sachiko Kuwayama [Japon] ; Yumiko Muraki [Japon] ; Noriko Kanamaru [Japon] ; Hiroko Takai [Japon] ; Chika Okada [Japon] ; Yayoi Sakaguchi [Japon] ; Izumi Furukawa [Japon] ; Kyoko Yamada [Japon] ; Makoto Matsumoto [Japon] ; Tetsuo Kase [Japon] ; Daphne E. Demello [États-Unis] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
001797 (2004) Jian-Ping Guo [Canada] ; Martin Petric ; William Campbell ; Patrick L. McgeerSARS corona virus peptides recognized by antibodies in the sera of convalescent cases.
002007 (????) Y-Z Chen [Japon] ; G. Liu ; S. Senju ; Q. Wang ; A. Irie ; M. Haruta ; M. Matsui ; F. Yasui ; M. Kohara ; Y. NishimuraIdentification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Viral Vaccines" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Viral Vaccines" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Viral Vaccines
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021